Account
News
02.10.2014
Incl. latest news on NICE's Value Based Assessment

Updates on the latest news on NICE's Value Based Assessment, as well as the approval of ultra-orphan...

Read more
News
07.07.2014
Incl. Is 2015 a turning point for bio similar

Including Sovaldi's $84,000 price, adaptive licence pilots from the EMA and is 2015 a turning point ...

Read more
News
20.05.2014
The latest in pharma pricing and market access

Our quarterly newsletter shares our perspectives on the latest news, developments and thinking withi...

Read more
Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch